DNB Asset Management
Anesa Mulabecirovic, MD PhD MBA, currently serves as DNB Healthcare and DNB Biotechnology at DNB Asset Management since June 2021. Previously, Anesa worked as an Investment Professional at Hadean Ventures and as an Expert Evaluator for The Research Council of Norway, contributing to the evaluation of applications for commercialisation projects. Anesa held leadership roles as President of the Norwegian Society for Diagnostic Ultrasound in Medicine and as a Board Member of the European Society of Ultrasound (EFSUMB). Anesa has a strong background in gastroenterology, with experience as a Project Manager at Helse Vest and board member of the National Advisory Unit for Ultrasound in Gastroenterology. Academic credentials include a PhD from the University of Bergen and King's College London, an MD from Universität zu Lübeck, and an MBA from the Norwegian School of Economics.
This person is not in any teams
This person is not in any offices
DNB Asset Management
1 followers
DNB Asset Management er Norges eldste og største kapitalforvaltningsselskap. Vi tilbyr verdipapirfond og forvaltningstjenester til privat- og bedriftskunder i Norge og internasjonalt. Vi har forvaltningsvirksomhet i Norge (DNB Asset Management AS) og i Luxembourg (DNB Asset Management S.A.). Vi tilbyr både indeksfond og aktivt forvaltede aksjefond innenfor en rekke markeder og sektorer, rentefond som investerer i rentepapirer med ulik bindingstid og kredittkvalitet i Norge, Norden og globalt - og fond som kombinerer investeringer på tvers av ulike aktivaklasser. I tillegg tilbyr vi spesialfond innenfor private equity og private debt. I tilfeller hvor kunden ønsker et skreddersydd forvaltningsprodukt kan vi dessuten, innenfor rammen av vår forvaltningsekspertise, tilby egne kundetilpassede investeringsporteføljer.